CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 17, 2006--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company developing and commercializing oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, announced today that Renato Fuchs, Ph.D., has been appointed Senior Vice President, Manufacturing and Technical Operations. In this role, Dr. Fuchs will oversee all aspects of manufacturing operations as the Company continues to advance its two lead product candidates, ALTU-135 and ALTU-238, toward Phase III clinical development.
